A Continuous Performance Test (CPT) was incorporated into a smartphone application (App) to measure three symptom domains associated with Attention Deficit Hyperactivity Disorder (ADHD); attention, impulsivity and hyperactivity. The App was pilot tested on 11 healthy adults over three testing sessions. No differences in performance were found between testing sessions suggesting good test consistency. A decrement in performance over time was only found for one measure of attention and on one testing session. The CPT showed some sensitivity to ADHD-related symptoms where self-reported impulsive behaviour was related to the CPT measures of impulsivity and activity. User acceptability was good although some design improvements were suggested. Further pilot testing of the App in a clinical population is needed.
Background
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental syndrome that is characterised by three core behaviours; inattention, hyperactivity and impulsivity and often persists into adulthood [1, 2, 3] . It is typically thought that between 3 and 5% of school aged children have the disorder (National Institute for Health and Clinical Excellence) [4] .
It has been suggested that ADHD stems from multiple causes, such as genetics, biological and psychosocial influences [5] , and results in a range of pathological behaviours [6, 7] . There is no single gene that is considered to underpin ADHD.
Instead, it is thought to arise from the combination of multiple genes, each gene having a small effect [5, 8] . ADHD often overlaps with other disorders and can have negative long-term consequences including increased risk of school failure, unemployment and mental health difficulties [1, 9] .
Given the variation in symptoms and behavioural consequences of ADHD, diagnosis, symptom monitoring and response to medication often relies on subjective interpretation of information gained through clinical interview and standardised rating scales. More recently, psychometric tests are used in the assessment process to provide objective measures of patient's symptoms. Such measures of cognitive function also offer the potential to objectively measure response to medication, and could potentially hasten the process of treatment optimisation [10] .
One such standardised test is the continuous performance test (CPT) which is a neuropsychological test that measures attention and impulsivity during a sustained task. Typically, a CPT is a computer based programme which involves rapid presentation of visual or auditory stimuli. Participants are asked to respond when a given target occurs but remain passive to non-targets [11] . A commonly used CPT is one where a sequence of letters is displayed such that a response is required for a display of the letter X only after the letter A (visual AX-CPT). Missing responses (Omission Errors), incorrect responses (Commission Errors) and reaction time (RT) are recorded. This CPT is preferable to using the X-CPT in adults where ceiling effects are often found [2] . These kinds of objective tests are commonly used to assess attention [10] and are considered to be the most sensitive assessment of medication effects [12] . Studies have shown a clear separation on CPTs between people with ADHD and controls, with ADHD participants showing poorer performance on measures of attention and impulsivity [13, 14] . Nevertheless, controversy remains as to whether CPTs are capable of distinguishing between ADHD and other disorders [2] .
Hyperactivity is one of the core symptoms of ADHD and is usually measured by subjective standardised rating scales. Some objective measures of attention now incorporate motor activity measures using actigraphs [15] or infra-red motion analysis [10, 16, 17] to give a fuller picture of the range of symptoms associated with ADHD. Such cognitive tests with motion analysis can reliably differentiate children [10, 17] and adults with ADHD [3] from controls and can provide a good measure of treatment response, with the potential for speeding up treatment optimisation [10] .
Such measures are confined to clinic visits, which are time consuming and costly, therefore a cost effective way of remotely and objectively monitoring symptoms without patients having to attend clinic would be useful. The aim of this pilot study is to see whether a CPT can be incorporated into a smartphone application whilst also measuring motion activity throughout the course of the task.
With the recent rise in the use of smartphones and the advances in technology, mobile software applications (Apps) are now being used in healthcare. Although software applications with relevant features are available on other devices such as personal computers and laptops, smartphones (and some smaller tablets) have the advantage of being portable and are more often than not in the owner's possession. This allows the user to stay in touch with people (whether they be friends, family or healthcare professionals) and access information or receive support via the internet at
